Total Payments
$7,435
2024 Payments
$228.20
Companies
27
Transactions
69
Payment Breakdown by Category
Food & Beverage$7,435 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,435 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $806.20 | 7 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $612.12 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $569.09 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $467.86 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $432.87 | 4 | $0 (2018) |
| TESARO, Inc. | $431.39 | 4 | $0 (2019) |
| Celgene Corporation | $368.68 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $358.92 | 4 | $0 (2020) |
| ABBVIE INC. | $340.84 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $337.68 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228.20 | 2 | AstraZeneca Pharmaceuticals LP ($120.23) |
| 2023 | $823.98 | 7 | Pharmacyclics LLC, An AbbVie Company ($336.03) |
| 2022 | $82.65 | 1 | E.R. Squibb & Sons, L.L.C. ($82.65) |
| 2021 | $380.50 | 3 | GlaxoSmithKline, LLC. ($142.51) |
| 2020 | $311.17 | 4 | Daiichi Sankyo Inc. ($119.59) |
| 2019 | $1,910 | 18 | Genentech USA, Inc. ($316.42) |
| 2018 | $2,927 | 27 | Janssen Scientific Affairs, LLC ($432.87) |
| 2017 | $771.61 | 7 | Genentech USA, Inc. ($125.00) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $107.97 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: Oncology | ||||||
| 11/07/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $106.36 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: Oncology | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 06/20/2023 | AbbVie Inc. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $106.85 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2023 | EMD Serono, Inc. | TEPMETKO (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Oncology | ||||||
| 02/08/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $122.82 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $82.65 | General |
| Category: Oncology | ||||||
| 11/16/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $142.51 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2021 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $112.99 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2021 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: BioOncology | ||||||
| 03/07/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $50.01 | General |
| Category: Oncology | ||||||
| 03/07/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Oncology | ||||||
| 02/05/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $119.59 | General |
| Category: Oncology | ||||||
| 01/23/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $106.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $89.78 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $115.94 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2019 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Food and Beverage | In-kind items and services | $126.42 | General |
| Category: BioOncology | ||||||
| 08/27/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $124.86 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: BioOncology | ||||||
| 07/30/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hematology / Oncology | ||||||
| 07/23/2019 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $120.36 | General |
| Category: Oncology | ||||||
| 07/18/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $102.57 | General |
| Category: Oncology | ||||||
About Dr. John Bismayer, MD
Dr. John Bismayer, MD is a Hematology & Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902899214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Bismayer, MD has received a total of $7,435 in payments from pharmaceutical and medical device companies, with $228.20 received in 2024. These payments were reported across 69 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,435).
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location Cincinnati, OH
- Active Since 08/23/2005
- Last Updated 11/02/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902899214
Products in Payments
- DARZALEX (Biological) $588.23
- ZEJULA (Drug) $573.90
- IMBRUVICA (Drug) $539.59
- TECENTRIQ (Biological) $489.78
- OPDIVO (Biological) $447.73
- KEYTRUDA (Biological) $337.68
- Imbruvica (Drug) $276.09
- Revlimid (Drug) $254.20
- IMFINZI (Biological) $241.64
- XTANDI (Drug) $238.28
- EPKINLY (Drug) $227.67
- Cabometyx (Drug) $221.44
- JAKAFI (Drug) $200.00
- IBRANCE (Drug) $145.99
- Herceptin (Biological) $126.42
- TAGRISSO (Drug) $125.00
- Tarceva (Drug) $125.00
- Kyprolis (Biological) $121.91
- TEPMETKO (Drug) $121.84
- EMPLICITI (Biological) $121.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cincinnati
Dr. David Waterhouse, Md, MD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Elyse Lower, Md, MD
Hematology & Oncology — Payments: $386,700
Hematology & Oncology $386,700
Dr. Alexander Starodub, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $254,325
Hematology & Oncology $254,325
Dr. James Essell, Md, MD
Hematology & Oncology — Payments: $223,019
Hematology & Oncology $223,019
Davendra Sohal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $124,378
Hematology & Oncology $124,378
Dr. Edward Faber, D.o., M.s, D.O., M.S
Hematology & Oncology — Payments: $116,895
Hematology & Oncology $116,895